ZURICH/LONDON, Dec 17
A weekly diabetes drug from Roche met its goals in two late-stage clinical trials, part of a series of studies required for approval, the Swiss drugmaker said on Thursday.
Uncover the stories others won’t tell. Subscribe now for exclusive access
- Unlimited access to all premium content
- Uninterrupted ad-free browsing experience
- Mobile-optimized reading experience
- Weekly Newsletters
- MPesa, Airtel Money and Cards accepted